BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3431518)

  • 1. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
    Jansen W; Geppert R; Weidmann B; Tauchert M
    Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
    Smolarz A; Seeliger S; Glocke M
    Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of retard and non-retard forms of isosorbide-5-mononitrate in coronary patients with stable angina pectoris].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Romasiuk SS; Afanas'eva IuV; Naumov VG
    Klin Med (Mosk); 2000; 78(11):36-8. PubMed ID: 11232528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-release isosorbide mononitrate for angina.
    Med Lett Drugs Ther; 1994 Feb; 36(915):13-4. PubMed ID: 8283957
    [No Abstract]   [Full Text] [Related]  

  • 8. Is isosorbide mononitrate better than the dinitrate?
    Drug Ther Bull; 1984 Jan; 22(2):7-8. PubMed ID: 6363029
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic effect of 20 mg and 50 mg of 5-isosorbide mononitrate in acute and chronic therapy].
    Jansen W; Osterspey A; Fuchs M; Tauchert M; Schell U; Weste S; Hombach V
    Med Welt; 1982 Dec; 33(48):1756-62. PubMed ID: 6818416
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ergometric evaluation of slow-release isosorbide-5-mononitrate in exertional angina with stable threshold].
    Fazzini PF; Pucci P
    Cardiologia; 1987 Nov; 32(11):1297-302. PubMed ID: 3447703
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemodynamic effects of isosorbide-5-mononitrate at rest and during exertion in patients with serious angina pectoris].
    Biamino G; Oeff M; Andresen D; Lichey HJ; Prokein E; Arntz R; von Leitner E; Schröder R
    Med Welt; 1981 Apr; 32(14A):535-9. PubMed ID: 7242316
    [No Abstract]   [Full Text] [Related]  

  • 12. [Time-dependent hemodynamic effects of monosan (Isosorbide-5-mononitrate) in anginal patients].
    Zholdin BK; Zaslavskaia RM; Zhamankulov KA
    Klin Med (Mosk); 1998; 76(4):30-2. PubMed ID: 9613078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of nitrates in modern coronary therapy].
    Klütsch K; Grosswendt J; Schöniger F; Koch E
    Z Kardiol; 1985; 74 Suppl 1():9-14. PubMed ID: 3922144
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
    Neuhaus R; Johnen R; Vydra L; Solbach C
    Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of isosorbide-5-mononitrate on the circadian rhythm of angina pectoris.
    Ganzinger U
    Arzneimittelforschung; 1992 Mar; 42(3):307-10. PubMed ID: 1497689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow release isosorbide-5-mononitrate therapy in angina pectoris. Effects of exercise performance and hemodynamics.
    Jansen W; Prenzel R; Rappert B; Kümper H; Laufen H; Tauchert M
    Cardiology; 1991; 79 Suppl 2():78-85. PubMed ID: 1760835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comments on 'A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily and isosorbide dinitrate twice daily in patients with stable angina'.
    Nyberg G
    Int J Cardiol; 1997 Jun; 60(1):107-10. PubMed ID: 9209948
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
    Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
    Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in the use of nitrates for treatment of angina pectoris.
    Ankier SI; Warrington SJ; Sneddon JM
    J Int Med Res; 1988; 16(4):249-56. PubMed ID: 3139481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term therapy with nitrates. How can continuous effectiveness be achieved?].
    Rudolph W; Dirschinger J; Reiniger G; Beyerle A
    Fortschr Med; 1989 Jun; 107(19):41-2, 45-7. PubMed ID: 2668139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.